A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing Ulf PerssonJohanna SvenssonBillie Pettersson Current Opinion 12 December 2012 Pages: 217 - 225
Economic Consequences of the Demography of MRSA Patients and the Impact of Broad-Spectrum Antimicrobials Klaus KaierS. Moog Short Communication 12 December 2012 Pages: 227 - 234
Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany Michael BäumlerTom StargardtReinhard Busse Original Research Article 12 December 2012 Pages: 235 - 248
Resource Utilization and Outcomes in Patients with Atrial Fibrillation Rachael BoggonGregory Y. H. LipTjeerd P. van Staa Original Research Article 12 December 2012 Pages: 249 - 259
Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece Georgia KourlabaVassilis FragoulakisNikos Maniadakis Original Research Article 12 December 2012 Pages: 261 - 271
Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures Avram A. EdidinKevin L. OngSteven M. Kurtz Original Research Article 12 December 2012 Pages: 273 - 284
